Every trade that managers of KP Tissue Inc. disclose to SEDI is tracked on this page. Between 18 October 2025 and 18 October 2026, 10 insiders published 20 filings.
On the market, 1 insider bought (1 purchase totalling €5,842) while 1 insider sold (3 sales totalling €54k). The net balance comes to €48k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 senior executive. Biggest ticket of the year: €30k, sold by Spraley, David A and made public on 17 June 2026.
The most recent open-market purchase was published on 1 October 2026, 16 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For context, the typical company on the same exchange (median of 2,140 companies) published 12 filings over the same period, against 20 filings here. Our records for KP Tissue Inc. go back to 2026, with 1 purchase and 3 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Analysts rate KP Tissue Inc. Hold (neutral), based on 4 analysts. Average price target: CA$12.88.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
20 of 20 declarations
KP Tissue Inc. is a Canadian company that specializes in the manufacturing of paper products, including tissues and paper towels. It is listed on the Toronto Stock Exchange under the symbol KPT.
Insider filings
Over the last 90 days, 10 filings published between 24 July and 16 October 2026: 1 open-market purchase by insiders for €5,842. 9 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Kruger, Sarah Astrea (4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)), purchases of €5,842.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)